Has Neil Farbman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,779 in general payments to Neil Farbman, MD across 64 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Neil Farbman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Neil Farbman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Neil Farbman, MD

Ophthalmology · Madison, WINPI 1861751364

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,125 of the $12,779 with a category attached, or 79.2%. Rxsight Inc accounts for 83.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $8,124 and has fallen 60.0% since, to $3,247 in 2025. Among ophthalmology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,779in general payments, 2019–2025

Across 64 payments — averaging $199.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Rxsight Inc$11K
Alcon$1K
Johnson & Johnson Surgical Vision, Inc.$251
Glaukos Corporation$169
Harrow Eye, LLC$87
Dompe US, Inc.$87
plus $244 from 6 others

What the payments were for

Consulting fees$10,12579%
Speaking & faculty fees$260%
Food & beverage$2,50720%
Gifts$1211%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Rxsight Inc	12	$10,633
Alcon	26	$1,307
Johnson & Johnson Surgical Vision, Inc.	5	$251
Glaukos Corporation	2	$169
Harrow Eye, LLC	4	$87
Dompe US, Inc.	3	$87
Genentech USA, Inc.	4	$77
ANI Pharmaceuticals, Inc.	2	$53
Sun Pharmaceutical Industries Inc.	2	$52
AbbVie	2	$33
Bausch & Lomb Americas Inc.	1	$15
Thea Pharma Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$7,771
RXSIGHT CONTACT LENS$2,726
RXSIGHT INJECTOR CARTRIDGE$2,726
RXSIGHT INJECTOR HANDPIECE$2,726
RXSIGHT LIGHT DELIVERY DEVICE (LDD)$2,726
LIGHT ADJUSTABLE LENS (LAL)$2,613
Clareon$340
Tecnis IOL$248
Clareon PanOptix Pro$145
iStent inject W$128
CATALYS SYSTEM$124
RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$113

How this compares

$12,779 in reported general payments places this provider in the 95th percentile of 337 ophthalmology providers in Wisconsin.

See all ophthalmology providers in Wisconsin →

Medicare billing

Part B allowed, 2024

$217,661

Medicare patients

272

Services billed

1,169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	1,017	$37,213
Ketorolac Tromethamine	790	$10,353
Ofloxacin	769	$7,619
Fluorometholone	50	$4,299
Dorzolamide-TimololDorzolamide/Timolol/Pf	15	$2,330
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol	18	$1,201
MoxifloxacinMoxifloxacin Hcl	32	$742
Brimonidine Tartrate	32	$308
Latanoprost	39	$308
Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim	36	$209
ErythromycinErythromycin Base	20	$203
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha	13	$145
Timolol Maleate	11	$51

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Madison

Michael ShapiroMadison$71K
Julia AgapovMadison$26K
Eric WeinlanderMadison$9K
Gordon CrabtreeMadison$8K
Paul KaufmanMadison$6K
Andrew ThliverisMadison$5K
Shahed GhoghawalaMadison$4K
Sina Rashidi KikanlooMadison$4K
Suzanne van LandinghamMadison$4K
Roomasa ChannaMadison$2K

See the full list for Wisconsin →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →